Search Results: "PARP inhibitor"

• Science & Technology

International Women’s Day: a Wikipedia edit-a-thon for women in cancer research 

Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that. Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that.

8 March 2019

• For Researchers

Celebrating a lifetime in cancer biology, an early diagnosis champion, and our leaders of tomorrow: the 2018 CRUK Research Prizes

We've awarded our annual research prizes at the NCRI Conference in Glasgow. Find out who won our Future Leaders, Jane Wardle, and Lifetime Achievement prizes. We've awarded our annual research prizes at the NCRI Conference in Glasgow. Find out who won our Future Leaders, Jane Wardle, and Lifetime Achievement prizes.

19 December 2018

• Health & Medicine

Targeted drug could slow progression of ovarian cancer in women with faulty BRCA gene

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research. A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research.

24 October 2018

• Science & Technology
• Health & Medicine

Scientists exploit leaks in blood brain barrier to treat glioblastoma

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma. An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma.

6 November 2017

• Science & Technology
• Health & Medicine

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer. In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

9 September 2017

• Health & Medicine

Targeted drug helps keep some advanced ovarian cancers at bay

Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening. Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.

8 September 2017

• For Researchers

Rucaparib: targeting DNA repair and a patient's perspective

Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib. Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib.

21 July 2017

• Charity News

Reviewing our year

Read about some of the progress we've made over the last financial year and about some of the big themes from the year. Read about some of the progress we've made over the last financial year and about some of the big themes from the year.

20 July 2017

• Health & Medicine

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer. Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

19 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017